.

@TrendSpider How do actually do it. @AndrewDudum @HimsHersComms @wearehims

$HYMC Absolutely relentless insider buying from Canadian billionaire Eric Sprott: 💰Purchases: $22.2M @ $2.33 $40.0M @ $2.85 $50.0M @ $6.50 $4.0M @ $8.00 $4.4M @ $8.80 $4.7M @ $9.40 $4.1M @ $10.25 $24.1M @ $6.55 $3.5M @ $11.67 $698.4K @ $11.64 $1.5M @ $12.50 $532.0K @ $13.30 $2.6M @ $13.00 $2.6M @ $13.00 $3.2M @ $14.55 $2.4M @ $16.00 $2.5M @ $25.00 $5.0M @ $25.00 $9.1M @ $22.75 $2.6M @ $26.00 $676.3K @ $27.05 $6.6M @ $33.00 $5.0M @ $50.00 $9.2M @ $46.00

@Atticus44351 @himshouse This is what you do @AndrewDudum

I just sold my shares after listening to the earnings call (up until I wrote this). I lost about 2% so no biggie but management doesn't have a great handle on the business. There are better options out there right now to put the money into. Could move up or down from here but the fundamentals of the business aren't great.

$HIMS SHARE PRICE OFFICIALLY BACK TO PRE-GLP-1 LEVELS 🤯🤯🤯

@himshouse Thank you @AndrewDudum , 0 questions answered

🚨 BREAKING: THE $HIMS EARNINGS CALL JUST ENDED JUST ONE QUESTION ABOUT THE FDA/DOJ INVESTIGATION & GLP-1 PILL THE WORDS "NOVO NORDISK" DID NOT COME UP NO MENTION OF GRAIL'S TRIAL RESULTS EITHER 🐘🐘🐘

@TheLongInvest Moron

$HIMS Daily RSI is 8 Weekly RSI is 21 Earnings beat now out of the way Risk has reduced, time to start factoring in the acquisitions BOTTOM IS IN!!

@himshouse Wtf? @AndrewDudum

🚨 $HIMS DOES **NOT** MENTION "PEPTIDES" IN Q4 2025 SHAREHOLDER LETTER

@himshouse What are you doing? @AndrewDudum

🚨 $HIMS ADDED ONLY 40,000 NET NEW SUBSCRIBERS IN Q4 2025 A GAIN OF JUST +2% vs Q3 2025 🤯

@SOUKCOMMUNITY @AndrewDudum Haha 617m up from 600. Q1 est 600-625m. It’s ass

@hatapengar @AndrewDudum Double beat my guy

$HIMS it’s time

@earnings_guy @AndrewDudum @HimsHersComms better fucking nail it now

Expected numbers for $HIMS (Hims & Hers Health) earnings today after close:

@MichaelAlbertMD @alluriontech @AndrewDudum get it

🚨 BREAKING: FDA APPROVES NEW OBESITY DEVICE TECHNOLOGY - - - @alluriontech (NYSE: ALUR) announces FDA PMA approval for the Allurion Gastric Balloon System, featuring the Allurion Smart Capsule. 🔹 Swallowed in a ~15-minute office visit 🔹 No surgery, endoscopy, or anesthesia 🔹 Single administration → ~4 months of therapy 🔹 Naturally passes from the body 🔹 Indicated for adults with BMI 30–40 With approval from the U.S. Food and Drug Administration, Allurion can now reach ~80 million Americans within the indicated BMI range. Real-world and clinical data outside the U.S.: 📉 ~14% total body weight loss (single cycle) 📉 >20% with repeat cycles 📉 >20% when combined with low-dose GLP-1 therapy + virtual care A new non-pharmacologic, procedure-based option enters the U.S. obesity treatment landscape. 🔗businesswire.com/news/home/2026…

@Fibonacci_TA If hims grew at the same rate as from q2 -> q3 2025 That would put Q4 revenue at 658m

Are we ready for today, $HIMS crew?

@SimontheItalian @Investinc_Intel Just dreaming now but if hims grew at the same rate as from q2 -> q3 2025 That would put Q4 revenue at 658m

@Investinc_Intel in Q3 they did 600M $HIMS in Q4 alone, they launched menopause/perimenopause care, low-testosterone treatments, comprehensive Labs testing, and microdosing options for GLP-1s they will smash it in 2026 they started in Canada + integration of acquisitions like ZAVA

Analysts projections for $HIMS earnings today! Revenue: 619M EPS: $0.03 What are your projections?!

@Investinc_Intel HH est is 612m

@Investinc_Intel 619 is est

$HIMS looking to start the day strong! Does someone know something 👀

@Investinc_Intel If hims grew at the same rate as from q2 -> q3 2025 That would put Q4 revenue at 658m

@hatapengar It’s just trying to save the green for after earnings right…😂

@StockTrader_Max Just dreaming now but if hims grew at the same rate as from q2 -> q3 2025 That would put Q4 revenue at 658m

$HIMS Could you actually imagine being a short seller heading into $HIMS report tonight... - Weekly RSI at 23 - Daily RSI at 16 - 4H RSI at 20 Tonight $HIMS bulls will get clarity on whats gone on with regards to $NVO & the FDA and how they plan to act. This will result in clarity which will enable the stock to move higher 📈

@alc2022 What is your estimates?

Eric Schmidt was right. By the time a company gets into legal battle mode, they've already lost. We're going into $HIMS earnings tonight with maximum pessimism, but fundamentals are doing fine. And $HIMS is building an entirely new healthcare system.

@StockTrader_Max @himshouse expects 598m in revenue

$HIMS Report earnings tonight... +$600 million in revenue expected +16% in volatility.. Im a strong believer that the move will be 16% higher after the report 📈

@hubermanlab When peptides legal @hubermanlab ?

One point of striving to get great sleep is so that the occasional night of bad sleep doesn’t harm you. The whole point of eating clean is to feel great, but also so the occasional treat is no big deal. Anyone saying focusing on your health is a life of rigidity has it backwards.